VanEck Associates’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Buy |
52,223
+5,557
| +12% | +$102K | ﹤0.01% | 1063 |
|
|
2025
Q1 | $815K | Buy |
46,666
+1,869
| +4% | +$32.6K | ﹤0.01% | 1078 |
|
|
2024
Q4 | $776K | Buy |
44,797
+5,025
| +13% | +$87K | ﹤0.01% | 1071 |
|
|
2024
Q3 | $755K | Buy |
39,772
+4,366
| +12% | +$82.9K | ﹤0.01% | 1033 |
|
|
2024
Q2 | $545K | Buy |
35,406
+2,201
| +7% | +$33.9K | ﹤0.01% | 1064 |
|
|
2024
Q1 | $490K | Buy |
33,205
+759
| +2% | +$11.2K | ﹤0.01% | 1069 |
|
|
2023
Q4 | $463K | Buy |
32,446
+5,335
| +20% | +$76.1K | ﹤0.01% | 1059 |
|
|
2023
Q3 | $378K | Buy |
27,111
+1,124
| +4% | +$15.7K | ﹤0.01% | 1076 |
|
|
2023
Q2 | $306K | Buy |
25,987
+744
| +3% | +$8.76K | ﹤0.01% | 1121 |
|
|
2023
Q1 | $290K | Buy |
25,243
+1,308
| +5% | +$15K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $298K | Buy |
23,935
+10,630
| +80% | +$132K | ﹤0.01% | 1012 |
|
|
2022
Q3 | $175K | Sell |
13,305
-7,632
| -36% | -$100K | ﹤0.01% | 1053 |
|
|
2022
Q2 | $292K | Buy |
20,937
+482
| +2% | +$6.72K | ﹤0.01% | 1000 |
|
|
2022
Q1 | $305K | Buy |
20,455
+2,679
| +15% | +$39.9K | ﹤0.01% | 1026 |
|
|
2021
Q4 | $241K | Buy |
17,776
+7,492
| +73% | +$102K | ﹤0.01% | 1071 |
|
|
2021
Q3 | $151K | Buy |
10,284
+1,586
| +18% | +$23.3K | ﹤0.01% | 1071 |
|
|
2021
Q2 | $158K | Buy |
8,698
+153
| +2% | +$2.78K | ﹤0.01% | 1033 |
|
|
2021
Q1 | $148K | Buy |
8,545
+292
| +4% | +$5.06K | ﹤0.01% | 971 |
|
|
2020
Q4 | $143K | Buy |
8,253
+2,057
| +33% | +$35.6K | ﹤0.01% | 878 |
|
|
2020
Q3 | $85K | Buy |
6,196
+1,177
| +23% | +$16.1K | ﹤0.01% | 900 |
|
|
2020
Q2 | $72K | Buy |
5,019
+2,551
| +103% | +$36.6K | ﹤0.01% | 883 |
|
|
2020
Q1 | $27K | Buy |
2,468
+1,336
| +118% | +$14.6K | ﹤0.01% | 908 |
|
|
2019
Q4 | $24K | Buy |
+1,132
| New | +$24K | ﹤0.01% | 906 |
|